*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Doxycycline: Rare but Real Cause of DILI (Drug-Induced Liver Injury)

Author: SHRAVAN KOORAGAYALU, MD,, FNU SREELAKSHMI, MD
Abstract: Drug-induced liver injury (DILI) is defined as an injury to the liver caused by a variety of medications, herbs and herbal products leading to abnormalities in liver tests after reasonable exclusion of other etiologies. Antibiotics, especially doxycycline is a less likely cause of hepatotoxicity. Here, we present an interesting case of idiosyncratic liver injury caused by Doxycycline. A 57-year old African American male presented to our hospital for an exacerbation of Chronic Obstructive Pulmonary Disease and was started on treatment with albuterol-ipratropium nebulization, Prednisone and Doxycycline. The following day, the patient started to complain of pain in the right upper quadrant and work up revealed deranged liver function tests, Right Upper Quadrant Ultrasound was normal. Doxycycline was suspected to be the cause of transaminitis. Other etiologies for liver injury were considered and excluded. Doxycycline was stopped and replaced with azithromycin. The patient's symptoms and the liver function abnormalities improved and were back to baseline in one week. This was a unique observation of doxycycline causing a mixed pattern of liver injury. We suggest clinicians have a high index of suspicion to avoid untoward consequences of drug-induced reactions.
Keyword: Drug-Induced Liver Injury, Immuno-allergic, Hepatocellular, Cholestatic, Roussel-Uclaf Causality Assessment Method (RUCAM) score.
DOI: https://doi.org/10.31838/ijpr/2020.SP1.053
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free